Cryotherapy in the prevention of oral mucositis in patients receiving low-dose methotrexate following myeloablative allogeneic stem cell transplantation: A prospective randomized study of the Gruppo Italiano Trapianto di Midollo Osseo nurses group

Bone Marrow Transplantation

Volumn 39, Issue 6, 2007, Pages 347-352

  Gori, E ^a   Arpinati, M ^a   Bonifazi, F ^a   Errico, A ^b   Mega, A ^c   Alberani, F ^a   Sabbi, V ^a   Costazza, G ^d   Leanza, S ^e   Borrelli, C ^f   Berni, M ^f   Feraut, C ^e   Polato, E ^g   Altieri, M C ^h   Pirola, E ^h   Loddo, M C ⁱ   Banfi, M ^j   Barzetti, L ^k   Calza, S ^l   Brignoli, C ^m   Bandini, G ^a   De Vivo, A ^a   Bosi, A ^b   Baccarani, M ^a   more..

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

^d Hospital 'Centro Sud'   (Italy)

^e UNIVERSITY OF TURIN   (Italy)

^f UNIVERSITY HOSPITAL OF SIENA   (Italy)

^g Laboratory of Advanced Cellular Therapies   (Italy)

^h SAN GERARDO HOSPITAL   (Italy)

ⁱ UNIVERSITY OF CAGLIARI   (Italy)

^j UNIVERSITY OF MILAN   (Italy)

^k Azienda Ospedaliera Umberto I   (Italy)

^l UNIVERSITY OF GENOA   (Italy)

^m Hospital of Bergamo   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYTARABINE; FLUDARABINE; FOLINIC ACID; MELPHALAN; METHOTREXATE; THIOTEPA; THYMOCYTE ANTIBODY; TREOSULFAN;

ADOLESCENT; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CRYOTHERAPY; DISEASE DURATION; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG HALF LIFE; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; INCIDENCE; ITALY; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROPHYLAXIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; STOMATITIS; TREATMENT OUTCOME; UNIVARIATE ANALYSIS; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS; CHILD; CRYOTHERAPY; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; METHOTREXATE; MIDDLE AGED; STOMATITIS; TRANSPLANTATION, HOMOLOGOUS;

EID: 33947109059     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705590     Document Type: Article

References (20)

1. Scully C, Epstein J, Sonis S. Oral mucositis: A challenging complication of radiotherapy, chemotherapy, and radiochemotherapy: Part 1, pathogenesis and prophylaxis of mucositis. Head Neck 2003; 25: 1057-1070.
2. Scully C, Epstein J, Sonis S. Oral mucositis: A challenging complication of radiotherapy, chemotherapy, and radiochemotherapy. Part 2: Diagnosis and management of mucositis. Head Neck 2004; 26: 77-84.
3. Bellm LA, Epstein JB, Rose-Ped A, Martin P, Fuchs HJ. Patient reports of complications of bone marrow transplantation. Support Care Cancer 2000; 8: 33-39.
4. Tonis ST, Oster G, Fuchs H, Bellm L, Bradford WZ, Edelsberg J et al. Oral mucositis and the clinical and economic outcomes of Hematopoietic Stem-cell Transplantation. J Clin Oncol 2001; 19: 2201-2205.
5. Rubenstein EB, Peterson DE, Schubert M, Keefe D, McGuire D, Epstein J et al. Clinical practice guideline for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer 2004; 100 (S9): 2026-2046.
6. Mead G. Management of oral mucositis associated with cancer chemotherapy. Lancet 2002; 359: 815-816.
7. Mahood DJ, Dose AM, Loprinzi CL, Veeder MH, Athmann LM, Therneau TM et al. Inhibition of fluorouracil-induced stomatitis by oral cryotherapy. J Clin Oncol 1991; 9: 449-452.
8. Cascinu S, Fedeli A, Fedeli SL, Catalano G. Oral cooling (cryotherapy), an effective treatment for the prevention of 5-fluorouracil-induced stomatitis. Eur J Cancer B Oral Oncol 1994; 30B: 234-236.
9. Rocke LK, Loprinzi CL, Lee JK, Kunselman SJ, Iverson RK, Finck G et al. A randomized clinical trial of two different durations of oral cryotherapy for prevention of 5-fluorouracil-related stomatitis. Cancer 1993; 72: 2234-2238.
10. Lilleby K, Garcia P, Gooley T, McDonnell P, Taber R, Holmberg L et al. A prospective, randomize study of cryotherapy during administration of high-dose melphalan to decrease the severity and duration of oral mucositis in patients with myeloma undergoing autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 2006; 37: 1031-1035.
11. Meloni G, Capria S, Proia A, Trisolini SM, Mandelli F. Ice pops to prevent Melphalan induced stomatitis. Lancet 1996; 347: 1691-1692.
12. Dumontet C, Sonnet A, Bastion Y, Salles G, Espinouse D, Coiffier B. Prevention of high dose L-Pam-induced mucositis by cryotherapy. Bone Marrow Transplant 1999; 14: 492-494.
13. Cutler C, Li S, Kim HT, Laglenne P, Szeto KC, Hoffmeister L et al. Mucositis after allogeneic hematopoietic stem cell transplantation: A cohort study of Methotrexate- and non Methotrexate-containing graft-versus-host disease prophylaxis regimens. Biol Blood Marrow Transplant 2005; 11: 383-388.
14. Bonini A, Bandini G, Cirio TM, Tosi P, Rosti G, Tura S. Methotrexate and delayed engraftment in allogeneic bone marrow transplantation. Bone Marrow Transplant 1995; 16: 729-730.
15. Chabner BA, Amrein PC, Druker BJ, Michaelson MD, Mitsiades CS, Goss PE et al. Antineoplastic agents. In: Brunton LL, Parker KL, Buxton IL, Blumenthal DK (eds). Goodman and Gilman's Pharmacology, 11th edition (on line), chapter 51. McGraw Hill: New York, 2006.
16. Robien K, Schubert M, Bruemmer B, Lloyd ME, Potter JD, Ulrich CM. Predictors of oral mucositis in patients receiving hematopoietic cell transplants for chronic myelogenous leukaemia. J Clin Oncol 2004; 22: 1268-1275.
17. Russell JA, Woodman RC, Poon MC, Jones AR, Ruether BA. Addition of low-dose folinic acid to a methotrexate/cyclosporin A regimen for prevention of acute graft-versus-host disease. Bone Marrow Transplant 1994; 14: 397-401.
18. Robien K, Schubert MM, Yasui Y, P Martin P, Storb R, Potter JD et al. Folic Acid supplementation during methotrexate immunosuppression is not associated with early toxicity, risk of acute graft-versus-host disease or relapse following hematopoietic transplantation. Bone Marrow Transplant 2006; 37: 687-692.
19. Nevill TJ, Tirgan MH, Deeg HJ, Klingemann HG, Reece DE, Shepherd JD et al. Influence of post-methotrexate folinic acid rescue on regimen-related toxicity and graft-versus-host disease after allogenic bone marrow transplantation. Bone Marrow Transplant 1992; 9: 349-354.
20. Spielberger R, Stiff P, Bensinger W, Gentile T, Weisdorf D, Kewalramani T et al. Palifermin for oral mucositis after intensive therapy for hematology cancer. N Engl J Med 2004; 351: 2590-2598.